Dr.
Fabrice Lucien-Matteoni is an Assistant Professor of Urology & Immunology at
Mayo Clinic focused on liquid biopsies and next-gen cancer immunotherapies. He
is also the Chair of the EV Blood Task Force.
His
research is focused on developing non-invasive blood and urine tests that can
facilitate cancer detection and prediction of response to specific therapies
for individual patients. In addition, Dr. Lucien-Matteoni is focused on
understanding the tumor-intrinsic mechanisms of immune evasion and resistance
to cancer therapies. His work serves as a scientific foundation for the
development of novel targeted therapies and immunotherapies for the treatment
of human cancers.
